BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

BMEDvsFHLCETF Comparison

ETF 1

BMED

iShares Health Innovation Active ETF

This fund is part of

Healthcare Technology

-1.76%

Full BMED fund page

VS

ETF 2

FHLC

Fidelity MSCI Health Care Index ETF

This fund is part of

US Health Care

-0.99%

Full FHLC fund page

iShares Health Innovation Active ETF (BMED) belongs to the Healthcare Technology segment. Fidelity MSCI Health Care Index ETF (FHLC) is part of the US Health Care segment. BMED's top 2 sector exposures are Healthcare and Non-Corporate. In contrast, FHLC's top sector exposures are Healthcare, Consumer Non-Cyclicals and Business Services. BMED is more expensive with a Total Expense Ratio (TER) of 0.77%, versus 0.084% for FHLC. BMED is up 14.51% year-to-date (YTD) with +$5M in YTD flows. FHLC performs better with 14.94% YTD performance, and +$473M in YTD flows. Run a side-by-side ETF comparison of BMED and FHLC below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

BMED vs FHLC performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 10/16/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	BMED FHLC	+3.05%+4.26%	+12.16%+7.85%	+14.51%+14.94%	+24.44%+24.97%	+54.98%+43.82%	+20.00%+42.84%
Flows	BMED FHLC	-+$72M	+$1M+$229M	+$5M+$473M	+$6M+$531M	+$7M-$201M	+$6M+$40M

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	BMED FHLC	+21.82%+16.49%	+17.81%+15.66%	+16.86%+14.87%	+18.13%+15.48%
Max drawdown	BMED FHLC	-5.85%-5.64%	-14.71%-10.35%	-19.76%-16.88%	-32.14%-17.78%
Max drawdown duration	BMED FHLC	31d56d	196d169d	237d435d	1479d762d

Trading data

Create an account to view trading data

Join for free

	BMED	FHLC
Last sale 10/19/2026 at 1:30 PM	$34.58	$84.25
Previous close 10/16/2026	$34.55	$84.55
Consolidated volume 10/16/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of September 30, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

BMED

is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free

	BMED	FHLC
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 10/19/2026 at 1:30 PM

Live

Closed

	BMED	FHLC
Last price	$34.58	$84.25
1D performance	+0.08%	-0.35%
AuM	$13.83 M	$3.75 B
E/R	0.77%	0.084%

Characteristics

	BMED	FHLC
Management strategy	Active	Passive
Provider	iShares	Fidelity
Benchmark	-	MSCI USA IMI Health Care 25/50 Index
N° of holdings	53	338
Asset class	-	-
Trailing 12m distribution yield	Join	Join
Inception date	September 29, 2020	October 21, 2013
ESG	No	No

More BMED data on Trackinsight

More FHLC data on Trackinsight

Exposure

Countries

BMED

USA

87.23%

Other

12.77%

FHLC

USA

97.14%

Other

2.86%

Sectors

BMED

Healthcare

98.95%

Other

1.05%

FHLC

Healthcare

98.23%

Other

1.77%

Diversification

BMED

Total weight of top 15 holdings out of 15

58.7%

FHLC

Total weight of top 15 holdings out of 15

60.85%

Top 15 holdings

Data as of August 31, 2026

BMED

Gilead Sciences, Inc.

5.01%

Merck & Co., Inc.

4.99%

AbbVie, Inc.

4.61%

Johnson & Johnson

4.27%

Charles River Laboratories International, Inc.

4.22%

Thermo Fisher Scientific, Inc.

4.12%

Edwards Lifesciences Corp.

3.95%

Moderna, Inc.

3.86%

IQVIA Holdings, Inc.

3.72%

Danaher Corp.

3.64%

Vertex Pharmaceuticals, Inc.

3.56%

Waters Corp.

3.53%

Biogen, Inc.

3.45%

Mettler-Toledo International, Inc.

3.16%

DexCom, Inc.

2.61%

FHLC

Eli Lilly & Co.

12.94%

Johnson & Johnson

8.88%

AbbVie, Inc.

6.21%

Merck & Co., Inc.

5.04%

UnitedHealth Group, Inc.

4.91%

Amgen, Inc.

3.21%

Thermo Fisher Scientific, Inc.

3.19%

Abbott Laboratories

2.69%

Gilead Sciences, Inc.

2.49%

Pfizer Inc.

2.19%

Vertex Pharmaceuticals, Inc.

1.90%

Danaher Corp.

1.89%

Bristol Myers Squibb Co.

1.87%

Intuitive Surgical, Inc.

1.82%

CVS Health Corp.

1.63%

Frequently asked questions about BMED and FHLC

How have the BMED and FHLC ETFs performed in 2026?

As of October 16, 2026, BMED is up 14.51% year-to-date (YTD), while FHLC has returned 14.94%. That puts FHLC better performer ahead so far this year.

Which ETF is attracting more investor money: BMED or FHLC?

Year-to-date, the BMED ETF saw +$5M in flows, compared to +$473M for FHLC.

Which ETF is more volatile: BMED or FHLC?

Over the past year, BMED had a volatility of 17.81%, while FHLC experienced 15.66%.

Which ETF is bigger: BMED or FHLC?

As of October 16, 2026, BMED holds $13.83 M in assets under management (AUM), while FHLC manages $3.75 B.

What sectors do the BMED and FHLC ETFs invest in?

BMED leans toward sectors like Healthcare. Meanwhile, FHLC focuses on Healthcare.

What are the top holdings of the BMED ETF and FHLC ETF?

BMED top holdings include Gilead Sciences, Inc., Merck & Co., Inc. and AbbVie, Inc.. FHLC holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

BMEDvsFHLCETF Comparison

iShares Health Innovation Active ETF

Fidelity MSCI Health Care Index ETF

BMED vs FHLC performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the BMED and FHLC ETFs performed in 2026?

As of October 16, 2026, BMED is up 14.51% year-to-date (YTD), while FHLC has returned 14.94%. That puts FHLC better performer ahead so far this year.

Which ETF is attracting more investor money: BMED or FHLC?

Year-to-date, the BMED ETF saw +$5M in flows, compared to +$473M for FHLC.

Which ETF is more volatile: BMED or FHLC?

Over the past year, BMED had a volatility of 17.81%, while FHLC experienced 15.66%.

Which ETF is bigger: BMED or FHLC?

As of October 16, 2026, BMED holds $13.83 M in assets under management (AUM), while FHLC manages $3.75 B.

What sectors do the BMED and FHLC ETFs invest in?

BMED leans toward sectors like Healthcare. Meanwhile, FHLC focuses on Healthcare.

What are the top holdings of the BMED ETF and FHLC ETF?

BMED top holdings include Gilead Sciences, Inc., Merck & Co., Inc. and AbbVie, Inc.. FHLC holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: BMED or FHLC?

BMED holds 55 securities with 58.7% of its assets in the top 15. FHLC has 338 securities and a top 15 weight of 60.85%.

ETFs’ Next Act: From Access to Selection